Russell AI Labs Launches to Build and Back Next-Generation Intelligent Technologies
Markus Schaefer, Mercedes-Benz Group AG CTO & Chairman of the Mercedes-Benz Grand Prix Ltd. Formula 1 Team, and Murtaza Ahmed, Former SoftBank Managing Partner,... Read more.
Introducing Logitech Signature Slim Solar+ K980 Keyboard
Powered by Light, No cables, No charging, Hassle-free performance Powered by Logi LightCharge technology, this new keyboard uses light from any light source to stay... Read more.
Cabot Properties Acquires Two Modern Industrial Properties in Germany
Recently built distribution facilities located in key logistics markets with strong economic fundamentals and population demographics MUNICH–(BUSINESS WIRE)–Cabot... Read more.
Northleaf Strengthens Private Credit Presence in the Netherlands with Investment in de Jong & Laan
Northleaf Supports Next Phase of Growth for Leading Audit and Accounting Firm LONDON–(BUSINESS WIRE)–Northleaf Capital Partners (“Northleaf”), a... Read more.
AWS and SAP Expand Collaboration to Advance Digital Sovereignty Across Europe
New sovereign cloud collaboration combines SAP enterprise applications expertise with AWS cloud infrastructure, enabling customers in highly regulated industries... Read more.
Loop 2025 State of Ecommerce Returns Report: UK retailers risk loyalty loss with 78% of returns ending in refunds and lowest exchange rates globally
Refunds dominate returns: UK’s refund ratio is 78.1%, meaning most returned value leaves brands entirely £100K in returned revenue on the line: urgent need to... Read more.
Omdia: LTPO to Surpass LTPS as Dominant Technology for Flexible Smartphone AMOLEDs in 2025
LONDON–(BUSINESS WIRE)–#AMOLED–Shipments of LTPO (Low-Temperature Polycrystalline Oxide) flexible AMOLEDs are expected to surpass those of LTPS... Read more.
Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025
– Ocrevus subcutaneous maintains consistent benefit-risk profile after two years – – New late-breaking data confirms Ocrevus significantly reduces... Read more.
ENHERTU® Plus Pertuzumab Granted Priority Review in the U.S. as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer
Based on DESTINY-Breast09 phase 3 trial results, which showed ENHERTU plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median... Read more.
Hanshow Strengthens Global Ecosystem by Partnering with Glintt Life and shopreme to Drive Smart Retail Digitalization
PARIS–(BUSINESS WIRE)–Hanshow, a global leader in digital retail solutions, is deepening its global ecosystem through strategic collaborations that connect... Read more.